vs
Side-by-side financial comparison of AUBURN NATIONAL BANCORPORATION, INC (AUBN) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
AUBURN NATIONAL BANCORPORATION, INC is the larger business by last-quarter revenue ($8.5M vs $6.5M, roughly 1.3× Prelude Therapeutics Inc). AUBURN NATIONAL BANCORPORATION, INC runs the higher net margin — 19.7% vs -303.5%, a 323.1% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs 8.4%).
Auburn Bank is an American community bank providing services in the East of Alabama as a state registered bank. The Bank offers financial products and services including checking, savings, and lending. The bank is a member of the Federal Home Loan Bank of Atlanta. Its operation is regulated by the Alabama Superintendent of Banks.
AUBN vs PRLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.5M | $6.5M |
| Net Profit | $1.7M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | 25.1% | -314.1% |
| Net Margin | 19.7% | -303.5% |
| Revenue YoY | 8.4% | 116.7% |
| Net Profit YoY | 6.7% | 38.9% |
| EPS (diluted) | — | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.5M | — | ||
| Q3 25 | $8.4M | $6.5M | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $7.8M | — | ||
| Q4 24 | $7.8M | — | ||
| Q3 24 | $7.6M | $3.0M | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.5M | — |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $2.2M | $-19.7M | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.7M | $-32.3M | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | 25.1% | — | ||
| Q3 25 | 33.9% | -314.1% | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 24.7% | — | ||
| Q4 24 | 30.6% | — | ||
| Q3 24 | 29.6% | -1145.9% | ||
| Q2 24 | 29.0% | — | ||
| Q1 24 | 20.3% | — |
| Q4 25 | 19.7% | — | ||
| Q3 25 | 26.5% | -303.5% | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | 19.6% | — | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 22.7% | -1075.7% | ||
| Q2 24 | 22.8% | — | ||
| Q1 24 | 18.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | $0.64 | $-0.26 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.50 | $-0.43 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $92.1M | $58.5M |
| Total Assets | $1.0B | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $153.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $92.1M | — | ||
| Q3 25 | $89.6M | $58.5M | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $83.1M | — | ||
| Q4 24 | $78.3M | — | ||
| Q3 24 | $84.3M | $156.4M | ||
| Q2 24 | $75.2M | — | ||
| Q1 24 | $74.5M | — |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $94.8M | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $996.8M | — | ||
| Q4 24 | $977.3M | — | ||
| Q3 24 | $990.1M | $197.2M | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $979.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $-19.1M |
| Free Cash FlowOCF − Capex | $10.9M | — |
| FCF MarginFCF / Revenue | 128.3% | — |
| Capex IntensityCapex / Revenue | 17.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $4.1M | $-19.1M | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $10.8M | — | ||
| Q3 24 | $1.9M | $-27.3M | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $3.1M | — |
| Q4 25 | $10.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 128.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 111.6% | — | ||
| Q3 24 | — | -912.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 17.5% | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 26.7% | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 7.42× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 1.72× | — | ||
| Q4 24 | 6.93× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 2.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
